RPE65 and retinal degeneration: Finally, to further test the ability of PE-eVLPs to mediate therapeutic in vivo prime editing, we applied PE-eVLPs to treat the rd12 mouse model77, which displays more severe retinal degeneration that allows evaluation of disease phenotype rescue.